U.S. Has Seen Steady Rise in Role of Alcohol, Drugs in Heart Deaths

Follow Drugslib on

Medically reviewed by Drugs.com.

By Dennis Thompson HealthDay Reporter

WEDNESDAY, Jan. 10, 2024 -- Heart disease deaths linked with alcohol or drug use have been steadily increasing in the United States, a new study has found.

Deaths from heart disease in which substance use was cited as contributor rose an average of 4% per year between 1999 and 2019, researchers report.

Further, the death rate accelerated in recent years, rising more than 6% from 2012 to 2019, according to findings published in the Journal of the American Heart Association.

This occurred even though overall deaths from heart disease declined during the same period.

“The study results were generally consistent with what we see in our clinic while caring for patients with cardiovascular disease,” senior author Dr. Dmitry Abramov, a cardiologist and associate professor of medicine at Loma Linda University Health in Loma Linda, Calif., said in a news release.

For the study, researchers reviewed publicly available death certificate data provided by the U.S. Centers for Disease Control and Prevention (CDC). They analyzed more than 636,000 heart disease deaths associated with substance use that occurred between 1999 and 2019. Overall, that rate rose from 9.9 deaths per 100,000 people in 1999 to 21.4 deaths per 100,000 in 2019.

Alcohol was most often implicated, playing a role in 65% of the deaths from heart disease, researchers found.

Heavy drinking is associated with high blood pressure, heart failure, stroke and obesity, according to Johns Hopkins Medicine.

Other substances involved in fatal heart disease included opioids (13.7%); cocaine (9.8%); stimulants (6.5%); sedatives (4.1%); and cannabis (0.5%).

“Although alcohol and opioids were the substances most associated with cardiovascular deaths, the increases in cardiovascular deaths related to stimulants (predominantly amphetamines) during the study period were particularly prominent,” Abramov said.

“This highlights both the ongoing risk of common substances, including alcohol and opioids, and also demonstrates the need to tackle amphetamines as a substance whose contribution to CVD deaths is growing more rapidly,” he added.

The largest increase in deaths occurred among 25- to 39-year-olds (5.3%), followed by adults age 55 to 69 (4.9%), results show.

In addition, increases in deaths were most prominent among women (4.8%), American Indian or Alaskan individuals (5.4%), and people living in rural areas (5%).

“We were surprised to see significant increases among individuals ages 25 to 39, compared to other age groups and among people in certain racial and ethnic groups, including white adults and American Indian/Alaska Native adults,” Abramov said.

While men had higher rates of deaths related to substance use, women showed larger increases during the study period, he pointed out.

Identifying high-risk groups will be key to prioritizing preventive measures, Abramov said.

Sources

  • American Heart Association, news release, Jan. 10, 2024

    • Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

    Source: HealthDay

    Posted : 2024-01-10 22:15

    Read more

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords